TMDX

Transmedics Group Stock Analysis

AI Rating

Great
  • Quality6/10
  • Growth↑ 9/10
  • Value↑ 5/10
Transmedics Group sales and earnings growth
TMDX Growth
Great
  • Revenue Y/Y↑ 27.81%
  • EPS Y/Y↑ 243.54%
  • FCF Y/Y↑ 339.39%
Transmedics Group gross and profit margin trends
TMDX Profitability
Great
  • Gross margin ↑ 59.10%
  • EPS margin↑ 27.00%
  • ROIC 5Y↓ 4.02%
Transmedics Group net debt vs free cash flow
TMDX Risk
Good
  • Debt / Equity↓ 1.7
  • Debt / FCF↓ 2.5
  • Interest coverage↑ 6.1

Transmedics Group stock volatility is in-line with the overall market. We give it a Good risk rating.

↗ More Medical Devices stocks